PODXL2 and acute myeloid leukemia: Upregulation of PRTFDC1 and PODXL2 expression was correlated with poor survival of AML, whereas downregulation of CCNL1 and RP11‐762I7.5 was correlated with poor survival of AML (Appendix Fig S5B).